Impact of Drug Therapy and Co-Morbidities on the Development of Renal Impairment in HIV-Infected Patients

CompletedOBSERVATIONAL
Enrollment

684

Participants

Timeline

Start Date

May 31, 2007

Study Completion Date

September 30, 2007

Conditions
Human Immunodeficiency VirusesKidney FailureHIV Infections
Trial Locations (1)

75215

Peabody Health Center, Dallas

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

AIDS Arms Inc.

OTHER

NCT00551655 - Impact of Drug Therapy and Co-Morbidities on the Development of Renal Impairment in HIV-Infected Patients | Biotech Hunter | Biotech Hunter